On Friday, the FDA warned against using Hologic Inc.’s (NASDAQ:HOLX) BioZorb Marker products and urged healthcare facilities to return all unused lots. This follows Hologic’s voluntary recall of the ...

Hologic (NASDAQ:HOLX) has recalled its implantable BioZorb and BioZorb LP Markers over concerns that they can cause irritation, infection and other health complications. The FDA said the devices were ...

In an updated safety communication dated October 25, the FDA states: “The U.S. Food and Drug Administration is alerting consumers, health care providers and health care facilities not to use BioZorb ...

Marlborough-based medical device manufacturer Hologic has been issued a warning letter from the U.S. Food and Drug Administration concerning its BioZorb Marker, a device originally recalled in March.

Hologic recently announced the voluntary recall of all unused lots of BioZorb markers and BioZorb LP markers due to reports of serious adverse events (AEs) occurring in patients who had the product ...

The FDA warns against BioZorb Markers due to serious side effects, prompting a voluntary recall by Hologic, Inc. BioZorb Markers are used for radiographic marking in soft tissue but are not for ...